Investigational Rotavirus Vaccine In Late-Stage Clinical Trials

Reuters: Sanofi’s Rotavirus vaccine enters late-stage trials “French drugmaker Sanofi said on Tuesday an investigational vaccine designed by its Shantha Biotechnics unit to protect young children from severe diarrhea had entered late-stage clinical trials in India. The vaccine is aimed at rotavirus infections which cause gastroenteritis…” (Callus, 10/14).

See the original post:
Investigational Rotavirus Vaccine In Late-Stage Clinical Trials